Categories
Health

Wish to Purchase a Scrunchie Masks? Nice. However Overlook About That N95.

“Amazon keeps changing the rules without explanation,” Atkinson said. “I know they’re not a charity, but a small company like ours doesn’t stand a chance.”

James Thomson, a former Amazon managing director who serves as chief strategy officer at marketing consultancy Buy Box Experts, said the tensions between online retail giants and small mask makers reflected the greater debate about the oversized power of online platforms to power the retail landscape dominated. Mr Thomson, whose company helps Marken steer Amazon’s complex sales policy, said his seemingly contradicting approach to N95 masks – claiming such goods are reserved for medical staff, but then allow exemptions for masks they are in bulk bought – is likely a result of Amazon’s loyalty strategy.

“Even if they’re making next to no money on this mask, the real thing is to keep customers happy so they don’t go elsewhere,” said Thomson. “The problem is, if you let these practices scale, it becomes disruptive to everything else that isn’t Amazon.”

It’s hard to overestimate the sales power of tech giants. Max Bock-Aronson, co-founder of Breathe99, a Minnesota start-up whose washable face mask filters out 99.6 percent of microscopic particles, said his company has been sick since Facebook dropped its ads in December, causing a decline of 50 percent resulted in sales. “Due to our cash flow crisis, we can only produce small quantities of masks, but these are sold out immediately,” said Bock-Aronson.

He is particularly annoyed by the company’s claims of having to protect the public as Facebook is unwilling to combat misinformation regarding political and pandemic-related content on its platforms.

“It’s just frustrating because we’re waving our hands and saying, ‘Hey, we have a better mask that can protect people,’ but we’re really not allowed to talk about it on their website,” he said. “It’s hard enough to start a business in normal times, but it’s nigh on impossible with those businesses excluding you from the market.”

In statements, Facebook, Google and Amazon said they had no immediate plans to revise their guidelines.

Categories
Health

2 folks had extreme allergic reactions after getting Covid vaccine

Empty vials containing a dose of the Johnson & Johnson vaccine against the COVID-19 coronavirus lie on a table as South Africa resumes its vaccination campaign at Klerksdorp Hospital on February 18, 2021.

Phill Magakoe | AFP | Getty Images

Two study participants suffered severe allergic reactions shortly after receiving the Covid-19 vaccine from Johnson & Johnson, a J&J scientist told an FDA panel on Friday.

J&J was first briefed on the allergic reactions on Wednesday, Macaya Douoguih, director of clinical development and medical affairs for the vaccines division at J&J, Janssen, told the FDA’s Advisory Committee on Vaccines and Related Biological Products.

One of the people took part in an ongoing study in South Africa and developed anaphylaxis, a severe and life-threatening allergic reaction, after receiving the vaccine.

She did not provide details on the second person’s reaction.

“We will continue to monitor these events closely,” she told the panel.

To date, there have been no reports of anaphylaxis in J & J’s clinical study. The Centers for Disease Control and Prevention is currently overseeing events such as the introduction of Pfizer and Moderna vaccines by states and pharmacies.

There were 46 reports of anaphylaxis in patients who received Pfizer’s vaccine and 16 cases in patients who received Moderna’s vaccine, according to a CDC report released on February 16. The agency said the incidence of the reaction is within the range of cases reported for the influenza vaccine.

The CDC urges healthcare providers to monitor patients for 15 minutes after vaccination and for 30 minutes for patients with a history of allergic reactions.

If someone has a severe allergic reaction after the first dose of the Covid-19 vaccine, the CDC recommends not receiving the second dose, even if the allergic reaction wasn’t severe enough to require emergency care.

Categories
Health

F.D.A. Skilled Panel Endorses Johnson & Johnson’s Vaccine

Johnson & Johnson’s Covid-19 vaccine was approved on Friday by a group of experts advising the Food and Drug Administration and cleared the final hurdle before formal approval expected on Saturday, according to two people familiar with the agency’s plans are. The nation’s first shipments will run out in the days thereafter.

It will be the third shot made available to the United States in the year since the first wave of coronavirus cases washed across the country, and it will be the first vaccine to require just one dose instead of two.

The Johnson & Johnson formulation worked well in clinical trials, especially against serious illness and hospitalization, although it did not match the sky-high efficacy rates of the first two vaccines from Pfizer-BioNTech and Moderna.

The panel, made up of independent infectious disease experts, statisticians and epidemiologists, voted unanimously to approve the vaccine.

“We are dealing with a pandemic right now,” said Dr. Jay Portnoy, an allergist at Children’s Mercy Hospital in Kansas City, MO, and a board member. “It’s great that we have this vaccine.”

During Johnson & Johnson’s presentation to the panel, Dr. Gregory Poland, a virologist at Mayo Clinic and the company’s paid external consultant, noted the vaccine’s effectiveness, ease of use and low side effect rate. It “checks almost all the boxes,” he said. “It is clear to me that the known benefits far outweigh the known risks.”

The vaccine had an overall effectiveness rate of 72 percent in the US and 64 percent in South Africa, where a worrying variant emerged in the fall. The shot showed an effectiveness of 86 percent against severe forms of Covid-19 in the US and 82 percent against serious illnesses in South Africa.

These are strong numbers, but they are below the efficacy rates of Pfizer-BioNTech and Moderna’s vaccines against mild, moderate, and severe cases of Covid of around 95 percent.

The Johnson & Johnson vaccine is a single dose and uses a different technology from the approved vaccines. The scope and size of the Johnson & Johnson trial was huge, spanning eight countries, three continents, and nearly 45,000 participants.

Although the vaccine works with one shot, studies are currently being carried out to see if a second dose would increase the level of protection.

Dr. Paul Offit, a pediatrician at Philadelphia Children’s Hospital and one of the panellists, pointed out Friday that Johnson & Johnson found in early clinical trials that took place over the summer that a second dose resulted in levels of coronavirus antibodies that were almost three times higher than those produced by one dose alone.

The results of the Johnson & Johnson late-stage two-dose clinical trial are not expected until July at the earliest. If these results are found to be better than a single dose, Dr. Offit: “Will this be a two-dose vaccine?”

Dr. Johan Van Hoof, the global director of vaccine research and development at Janssen Pharmaceuticals, the drug development arm of Johnson & Johnson, said the company decided to pursue the one-shot strategy after its studies on monkeys last spring showed that a single dose was sufficient to provide strong protection against the disease.

“It is clear that in a situation of an outbreak, in a raging epidemic, the big challenge is getting the epidemic under control,” he said. “The regime is very well positioned to be used in outbreak situations.”

Dr. However, Van Hoof also noted that it will be important to track volunteers who have received a single dose to see if their immunity changes over the coming months. Firing a booster shot may be required for long-term protection. “The big question mark is still how long does the protection last?” he said.

Following the vote, the FDA told Johnson & Johnson that it “will work quickly towards completion and emergency clearance,” a statement said. The FDA also said it had notified other government agencies “so they can implement their plans for timely vaccine distribution”.

Sharon LaFraniere contributed to the coverage.

Categories
Health

CDC scientist says the U.S. is ‘nowhere shut’ to herd immunity

People await vaccinations against coronavirus disease (COVID-19) at Martin Luther King Jr. Community Hospital in Willowbrook, Los Angeles, California on February 25, 2021.

Lucy Nicholson

The US is “far from” achieving herd immunity to Covid, and more communicable variants mean even more people will need to be vaccinated to reach them, a CDC scientist said Friday.

Herd immunity occurs when enough people in a particular community have antibodies to a particular disease, either through vaccination or through previous exposure to the virus. That makes it difficult to spread from person to person and protects even people who don’t have immunity.

“Currently we know that the majority of the US population is not immune to SARS-CoV-2 and variants can cause that portion of the population that is not immune to gain weight,” said Adam MacNeil, epidemiologist at Centers for Disease Control and Contraception.

Reaching the herd immunity threshold in combating new, contagious strains of the virus requires vaccinating a higher proportion of the population, MacNeil said at a meeting of the Food and Drug Administration at which Johnson & Johnson’s application for approval of the Covid-19- Emergency vaccine checked for use.

Scientists don’t believe that immunity lasts forever. It weakens over time, and that could make the outbreak worse as previously protected people become vulnerable to infection, MacNeil said.

His comments come a week after a Wall Street Journal statement claimed the U.S. would achieve herd immunity by April.

While virus variants have been shown to reduce the effectiveness of a Covid vaccine at protecting against infection, vaccines have been shown to be effective at preventing serious illness and hospitalization against the more infectious strains.

Increased vaccination would significantly slow current development of a highly contagious variant of Covid, first identified in the UK, as it became the dominant strain of virus in the US by March, MacNeil said.

He said increased vaccination was critical for the country to hit the benchmark.

“Vaccination has started and hopefully this brings us closer to closing the herd immunity gap.”

Categories
Health

New Findings on 2 Methods Kids Turn into Severely Ailing From the Coronavirus

A large nationwide study found important differences in the two main causes of serious illness in children from the coronavirus. These results can help doctors and parents better identify the conditions and understand more about the children at risk.

The study, published Wednesday in JAMA magazine, analyzed 1,116 cases of young people being treated in 66 hospitals in 31 states. Just over half of the patients had acute Covid-19, the predominantly lung-related disease that affects most adults with the virus, while 539 patients had the inflammatory syndrome, which in some children follows a typical mild one weeks Disease broke out, initial infection.

The researchers found some similarities, but also significant differences, in the symptoms and characteristics of the patients, who ranged from infants to 20-year-olds who were hospitalized between March 15 and October 31 last year.

Young people with the syndrome known as Pediatric Multisystem Inflammatory Syndrome, or MIS-C, were more likely to be between 6 and 12 years old, while more than 80 percent of patients with acute Covid-19 were either younger than 6 years or older were as 12.

More than two-thirds of patients with both conditions were Black or Hispanic, which experts say most likely reflects socio-economic and other factors that some communities have disproportionately exposed to the virus.

“It is still shocking that the vast majority of patients are not white, and that goes for MIS-C and for acute Covid,” said Dr. Jean A. Ballweg, Medical Director, Pediatric Heart Transplant and Advanced Heart Failure at Children’s Hospital & Medical Center in Omaha, who was not involved in the study. “There are clearly racial differences.”

For unclear reasons, while Hispanic adolescents appeared to be equally at risk for both conditions, black children appeared to be at greater risk for developing the inflammatory syndrome than the acute disease, said Dr. Adrienne Randolph, the study’s lead author and a specialist in pediatric intensive care at Boston Children’s Hospital.

One possible clue that the authors mention is that in Kawasaki disease, a rare childhood inflammatory syndrome that shares similarities with some aspects of MIS-C, black children are more likely to have cardiac abnormalities and are less responsive to one of the standard treatments: intravenous Immunoglobulin.

The researchers found that young people with the inflammatory syndrome were significantly more likely to have no underlying illnesses than those with acute Covid. Nevertheless, more than a third of patients with acute Covid had no previous illness. “It’s not that previously healthy children are completely unscathed here,” said Dr. Randolph.

In the study, obesity was assessed separately from other underlying health conditions and only in patients 2 years and older. It found that a slightly higher percentage of young people with acute Covid were obese.

Updated

Apr. 26, 2021 at 1:54 am ET

Dr. Srinivas Murthy, an associate professor of pediatrics at the University of British Columbia who was not involved in the study, said he was not convinced the results show that healthy children are at higher risk for MIS-C. It could “mostly be a numbers game where the proportion of infected children and the proportion of healthy children is out there, instead of saying that healthy children have something immune that puts them at disproportionately higher risk,” he said.

Overall, the study’s documentation of the differences between the two conditions was useful, especially because it reflected “a reasonably representative group of hospitals in the US.”

Young people with the inflammatory syndrome were more likely to have had to be treated in intensive care units. Her symptoms more commonly included gastrointestinal problems and inflammation, as well as skin and mucous membranes. They were also much more likely to have heart problems, although many of the acute Covid patients didn’t get detailed heart exams, the study said.

About the same large proportion of patients with any disease – more than half – required airway support, with slightly less than a third of patients requiring mechanical ventilation. About the same small number of patients in each group died: 10 with MIS-C and eight with acute Covid-19.

The data does not reflect a recent surge in inflammatory syndrome cases that followed a surge in total Covid-19 infections across the country during the winter holiday season. Some hospitals have reported that there were more seriously ill MIS-C patients in the current wave compared to previous waves.

“I’ll be intrigued to see a comparison with this group from November 1st because I think we all felt that the kids with MIS-C have been even sicker lately,” said Dr. Ball path.

An optimistic sign from the study was that most severe heart problems in young people with inflammatory syndrome improved to normal within 30 days. Dr. However, Randolph said any remaining effects are still unknown, which is why one of her co-authors, Dr. Jane Newburger, assistant director of academic affairs in the cardiology department at Boston Children’s Hospital, conducted a statewide study to track children with inflammatory syndrome for up to five years.

“We can’t say 100 percent for sure that everything will be normal in the long run,” said Dr. Randolph.

Categories
Health

Biden administration faucets personal firms, enterprise teams for assist in Covid struggle

United States President Joe Biden speaks about the 50 million doses of the Covid-19 vaccine administered in the United States during a landmark event in the Eisenhower Executive Office Building in Washington, DC on February 25, 2021.

Saul Loeb | AFP | Getty Images

On Friday, White House officials will unveil a new partnership between the administration and senior business groups to help with the national Covid-19 response and vaccine roll out, said Andy Slavitt, White House Senior Advisor on Covid Response, known.

The partnership includes the Chamber of Commerce, the Business Roundtable, the National Association of Manufacturers, and executives at Hispanic, African-American, Asian-American and other minority companies, Slavitt said.

The purpose of the partnership, a White House official told CNBC, is to urge businesses of all sizes to “promote public health actions to remove barriers to vaccination for employees and public health reporting related to masking.” and to improve vaccinations for their clients and communities. “The New York Times previously reported on the partnership.

Outside of the partnership, Walgreens and Uber are starting a pilot program to offer pharmacies free rides to get the Covid-19 vaccine. Other companies like Dollar General, Best Buy, and Target have announced that they will provide paid time off to compensate their employees for the vaccine.

Slavitt added that Lyft is partnering with CVS and the YMCA has also teamed up to offer 60 million free or discounted trips to help people get vaccinated. And Ford and The Gap have vowed to donate more than 100 million masks for free distribution.

“I wouldn’t portray these as a federal effort,” Slavitt said. “I would portray this as efforts by organizations across the country that we encourage others to take stock of in some cases.”

The White House, with its new business partners, will push more companies to do the same, Slavitt said.

Slavitt said administrative officials would be making calls to corporate groups over the next few weeks asking them to help with the federal response to the pandemic. He said the White House will urge them to oblige staff to follow public health precautions and educate the public about the importance of vaccination.

“First, masking and social distancing must be required to protect workers, customers, and others on the premises,” Slavitt said. Second, reduce barriers to vaccination. Make a plan to vaccinate employees and make it easier for employees to vaccinate by providing incentives such as paid time off or compensation for employees who get vaccinated when they attend Row are. “

Jay Timmons, president and CEO of the National Association of Manufacturers, said “no American is safe from COVID-19 until all Americans are safe,” said a statement. The group represents more than 12 million employees and 130,000 companies. “Manufacturers are proud to join the Biden administration in this call to arms.” He said the group and its members are determined to help end the pandemic.

Categories
Health

How Pandemic Isolation Affected an Alzheimer’s Affected person in a Nursing Residence

While the nurses came to change Peggy’s bedding, I spoke to her nurse in the hallway. When Peggy arrived at this facility about two weeks earlier, she had pressure ulcers on her heels and lower back. In Peggy’s room, her nurse changed her bandages and pointed out the wounds on her heels, which didn’t look bad, but on her back, just above her tailbone, a plate the size of a plate was sore, yellowish, and raw. “It’s gotten so much better,” said the nurse, running her finger over a circle about a third larger than the one I could see.

Both pressure ulcers and pulmonary embolisms can be caused by lying in the same position for too long. Nobody accused their previous nursing home of neglect, but they made it clear that the wounds were already there when they arrived. They had developed in the first four months of the Covid shutdown when my sister, her chief attorney, was not allowed to visit.

Her bandages changed and her sheets were fresh, Peggy turned on her side. Her eyes were calm and when she fell asleep I could see that she knew who I was.

While she slept, I explored her room to see what remnants of her curious and acquisitive life had been preserved in this institutional space. Her photo album was sticky and the pages crackled with age. I knew a lot of these photos. There she was like a bridesmaid, tall and deeply tanned, her blue eyes shining and holding the hand of our father, who lived not long after this picture was taken. There were photos of us as the five sisters we once were and one of Peggy, who was 10 years older than me and who acted as a surrogate mother when I graduated from high school. There was a photo of the friend who followed her to the end of the world, but to whom she could not commit. There are photos of our New Jersey home, nieces and nephews, green decks and swimming pools, and Peggy on her skis.

They came from a life none of us lived anymore, and they ended around 2005 when my mother sold her house and moved into assisted living, leaving Peggy without a landing for the first time in her life. Her bipolar illness, which she found difficult to manage, began to feed on the life she had built before Alzheimer’s quit the job.

Categories
Health

What to know earlier than key FDA panel vote

Vials of Johnson & Johnson’s Janssen Coronavirus Disease (COVID-19) vaccine candidate are shown in an undated photo during the Phase 3 ENSEMBLE trial.

Johnson & Johnson | via Reuters

A key advisory body to the Food and Drug Administration is due to vote on Friday on whether to recommend Johnson & Johnson’s emergency approval of the Covid-19 vaccine to pave the way for a third preventive treatment to be distributed in the United States

A positive vote by the Advisory Committee on Vaccines and Allied Biological Products will likely pave the way for the US agency to approve J & J’s emergency vaccine. The committee plays a pivotal role in getting vaccines approved in the U.S. and verifying that the shots are safe for public use. While the FDA does not need to follow the committee’s recommendation, it often does.

On similar inquiries from Pfizer and Moderna, the FDA approved these companies’ vaccinations the day after the committee of external medical advisors endorsed approval for the emergency. If J&J follows the pattern, a third vaccine could be approved on Saturday.

According to data from Johns Hopkins University, the US will need a range of drugs and vaccines to end the pandemic that has infected more than 28.3 million Americans and killed at least 505,899 people as of Thursday. Unlike Pfizer and Moderna’s vaccines, which require two doses three to four weeks apart, J&J only requires one dose, which makes logistics easier for healthcare providers. J & J’s vaccine, unlike the other two vaccines, can also be stored at refrigerator temperature for months.

Here’s what you can expect:

1. When do you vote?

The meeting is expected to take place from 9:00 a.m. to 5:30 p.m.

Prior to voting, medical experts will evaluate J & J’s clinical trial data and provide their opinion on the vaccine, including whether the benefits outweigh the risks of being approved for emergency use. The company is asking the FDA to approve use of the vaccine in people 18 years and older. Pfizer’s has been approved for use in people aged 16 and over. The poor data in younger teenagers was a sticking point for the few advisory board members who voted against approval of the Pfizer BioNTech vaccine in December.

2. What happens next?

The FDA will decide if J&J should clear the vaccine for emergency use. In the Pfizer and Moderna cases, the agency’s final decision came one day after the meeting.

Such approval by the FDA is not synonymous with full approval, which can usually take months longer. J&J, like Pfizer and Moderna, only submitted two months of safety data, but the agency typically takes six months for full approval

3. When will I get the vaccine?

Initially the doses would be limited. Jeff Zients, President Joe Biden’s Covid Tsar, told reporters Wednesday that the federal government expects to ship 3 to 4 million doses of J & J’s vaccine to states, pharmacies, and community health centers next week pending FDA approval .

The company expects to drop 20 million doses by the end of March, said Dr. Richard Nettles, vice president of medical affairs in the US, told the House legislature on Tuesday. J&J has signed a contract with the US government to supply 100 million doses of its vaccine by the end of June. Zients said the federal government will “do everything we can” to boost production.

4. Should I have the vaccine?

J & J’s vaccine provides 66% overall protection against Covid-19, compared to about 95% for Pfizer and Moderna’s vaccine. Some people have wondered if they should get the J&J vaccine because of the lower rate of effectiveness.

However, infectious disease experts point out that J & J’s results cannot be directly compared to the other two vaccines because it is a single dose and the company’s study was conducted when more infections emerged as well as new, more contagious variants .

The Chief Medical Officer of the White House, Dr. Anthony Fauci said Americans should take every approved vaccine they can get. He also notes that J & J’s vaccine prevented 100% of virus-related hospitalizations and deaths in its late-stage.

“The most important thing, more important than preventing someone from getting a pain and a sore throat, is preventing people from getting serious illnesses,” he told reporters when he called on Jan. 29. “This will relieve so much stress.” and human suffering and death in this epidemic. “

5. What are the side effects?

Analysis by age, race and comorbidity did not identify any specific safety concerns with the vaccine, according to an FDA report released on Wednesday.

Headache, fatigue, and muscle pain were some of the most common side effects in people who received the vaccination, the report said. There have also been reports of nausea, fever, and pain at the injection site. According to the report, there have been no reports of anaphylaxis, a severe and life-threatening allergic reaction.

The report identified a few cases of Bell’s palsy with half of your face drooping but “balanced” with the number commonly found in the general population. The FDA previously announced that the condition would be monitored in vaccine recipients after flagging it as a potential problem with Pfizer’s shots, and noted that this isn’t necessarily a side effect, but it is worth looking out for.

Medical experts say vaccine side effects are common and actually indicate that the shots are working as intended. The CDC recommends talking to a doctor about taking over-the-counter drugs if you experience pain or discomfort after the shot.

– CNBC’s Noah Higgins-Dunn contributed to this report.

Categories
Health

Studying to Take heed to Sufferers’ Tales

The pandemic has been a time of painful social isolation for many. Few places can be as isolating as hospitals, where patients are surrounded by strangers, subjected to invasive tests, and hooked up to a series of beep and gurgle machines.

How can the experience of receiving medical care be made more welcoming? Some say that having a sympathetic ear can go a long way in healing patients who are under the stress of hospitalization.

“It’s even more important now, when we can’t always see or touch patients’ faces, to really hear their stories,” said Dr. Antoinette Rose, an emergency doctor in Mountain View, California who now works with many patients sick with Covid.

“This pandemic has forced many caregivers to immerse themselves in the human stories that are playing out. They have no choice. They become “family” at the bedside, “said Dr. Andre Lijoi, medical director at York Hospital in Pennsylvania. Doctors, nurses, and others who assist with patient care “need time to slow down, take a breath, and listen”.

Both doctors find their inspiration in narrative medicine, a discipline that guides doctors in the art of listening deeply to those who come to them for help. Narrative medicine is taught in some form in approximately 80 percent of medical schools in the United States today. Students are trained in “sensitive interviewing skills” and the art of “radical listening” to improve the interaction between doctors and their patients.

“As doctors, we have to ask those who come to us, ‘Tell me about yourself,'” said Dr. Rita Charon, who founded Columbia University’s pioneering narrative medicine program in 2000. “We have fallen out of this habit because we think we know the questions we need to ask. We have a checklist of symptom questions. But there is an actual person in front of us who is not just a collection of symptoms.”

Columbia currently offers online training for medical students like Fletcher Bell, who says the course is helping to change the way he sees his future role as a healer. As part of his training as a storyteller, Mr. Bell stayed in virtual contact with a woman who was being treated for ovarian cancer. He described the experience of sharing as both heartbreaking and beautiful.

“It can be therapeutic just to listen to people’s stories,” noted Bell. “If there is fluid in the lungs, drain it. If there is a story in the heart, it is important to bring it out as well. It is also a medical intervention that is not easily quantified. “

This more personalized approach to medical care is not a new art. In the not too distant past, general practitioners often treated several generations of the same family and knew a lot about their lives. But as medicine became increasingly institutionalized it became faster and more impersonal, said Dr. Charon.

The typical doctor visit now takes 13 to 16 minutes, which is usually all insurance companies pay for. A 2018 study published in the Journal of General Internal Medicine found that the majority of doctors at the prestigious Mayo Clinic didn’t even ask people what the purpose of their visit was, and often interrupted patients talking about themselves.

Updated

Apr. 26, 2021, 1:26 p.m. ET

But this fast food approach to medicine is sacrificing something essential, says Dr. Deepu Gowda, assistant dean of medical education at Kaiser-Permanente School of Medicine in Pasadena, California, led by Dr. Charon was trained in Columbia.

Dr. Gowda recalls an elderly patient he saw during his stay who suffered from severe arthritis and whom he found angry and frustrated. He came to fear her office visits. Then he began to ask the woman questions, listening with interest as her personal story unfolded. He was so intrigued by her life story that he asked her permission to photograph her outside the hospital, which she granted.

Dr. Gowda was particularly impressed by a picture of his patient holding on to the railing of her walk-in apartment, stick in hand. “This picture represented their daily struggles for me,” he said. “I gave her a copy. It was a physical representation of the fact that I cared about who she was as a person. Her pain did not subside, but there was an ease and a laugh in those later visits that weren’t there before. There was some kind of healing that took place in this simple human appreciation. “

While few working doctors have the free time to photograph their patients outside of the clinic or delve deep into their life stories, “people pick it up” when the doctor shows genuine interest in them, said Dr. Gowda. You will trust such a doctor more and be motivated to follow their directions and return for follow-up visits, he said.

Some hospitals have started conducting preliminary interviews with patients before clinical work begins in order to get to know them better.

Thor Familler, a family therapist, started the My Life, My Story program in 2013 at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. Professional writers are hired to interview veterans – via telephone and videoconferencing since the pandemic outbreak – and compose a brief bio that is added to their medical record and read by their attending physician.

“My goal was to give veterinarians an opportunity to be heard in a large bureaucratic system in which they do not always feel heard,” said Ringler.

The program has expanded to 60 VA hospitals, including Boston, where over 800 veteran stories have been compiled over the past three years. Jay Barrett, nurse manager at VA Boston Healthcare System, said these biographies often provide important information that can serve as a guide to treatment.

“Unless they have access to the patient’s history,” Ms. Barrett said, “healthcare providers do not understand that this is a mother who looks after six children or who does not have the funds to pay for medication. ” or this is a veteran with severe trauma that needs to be addressed before even discussing how to deal with the pain. “

Dr. Lewis Mehl-Madrona, a family doctor who teaches at the University of New England in Biddeford, Maine, has examined veterans undergoing pain management. Those asked to share about their lives had less chronic pain and rated their relationship with their doctor higher than those who hadn’t. The doctors who requested the stories also reported greater job satisfaction and less emotional burnout, which has become a particularly worrying problem during the Covid pandemic.

The demands on the time of the healthcare workers have never been so high. However, proponents of narrative medicine say it takes only a few moments to establish an authentic human connection, even when the communication is online, as is often the case today. Dr. Mehl-Madrona argues that remote video conferencing platforms like Zoom can make it even easier to keep tabs on people at risk and solicit their stories.

Derek McCracken, a professor at Columbia University who helped develop training protocols for the use of storytelling in telemedicine, agrees. “Telehealth technology can be a bridge,” he said, “because it is a balance that forces both parties to slow down the conversation, be vulnerable, and listen carefully.”

The critical point for Dr. Flour madrona is that people asked to speak about themselves – whether in person or on screen – “don’t just throw themselves in to the doctor for repairs. They are actively involved in their own healing. “

“Doctors can be replaced by computers or nurses if they feel their only job is just to prescribe medication,” he added. “If we are to avoid the fate of the dodo bird, we need to establish dynamic relationships with patients and place symptoms in the context of people’s lives.”

Categories
Health

Moderna strikes ahead to extend Covid vaccine provide in every vial

A detail of the Moderna COVID-19 vaccine.

Allen J. Cockroaches | Los Angeles Times | Getty Images

Moderna said Monday it had “positive feedback” from the Food and Drug Administration on its proposal to increase the number of Covid-19 vaccine doses in each of its vials.

One vial of Moderna’s two-shot vaccine contains ten doses, enough to vaccinate five people, according to the Centers for Disease Control and Prevention. CNBC reported last month that Moderna had asked the FDA for permission to fill their Covid-19 vaccine bottles with up to five extra doses to remove a manufacturing bottleneck.

In a prepared statement filed ahead of a House hearing on Tuesday, Stephen Hoge, President of Moderna, said the US agency had “given the company positive feedback on our proposal and we are pursuing a plan that will keep the withdrawal up.” allows up to 15 doses from each vial. “

“That way we can produce and deliver more cans faster,” Hoge told the House Energy and Commerce Committee’s Oversight and Investigation Subcommittee. “We will continue to work with our manufacturing partners and the federal government to increase the efficiency of our production process without.” Impairment of quality or safety. “

The announcement comes as President Joe Biden tries to accelerate the pace of vaccinations in the US after a slower-than-expected rollout under former President Donald Trump and states are complaining that they are running out of doses.

Biden announced on Feb. 11 that his government had signed contracts with Pfizer and Moderna for an additional 200 million doses of Covid-19 vaccine, bringing the US number to 600 million. Since both approved vaccines require two doses three to four weeks apart, a total of 600 million doses would be enough to vaccinate 300 million people. The Biden government expects all of this to happen by the end of July.

It is unclear whether Moderna expects to be able to dispense 300 million doses by the end of July due to the increase in the doses per vial.

In December, the FDA announced that healthcare providers could use additional doses from vials of Pfizer’s Covid-19 vaccine. These vials are said to contain five doses, but some vendors have been able to extract a sixth or even a seventh dose. As with Pfizer, some vendors were able to use special syringes to obtain an additional dose of the Moderna vaccine.